A critical component of the adaptive anti-tumor response is cytotoxic CD8+ T cells, with importance further underscored by research demonstrating that blocking PD-1/PD-L1 signaling in tumor cells enhances CD8+ T cell infiltration and combats tumor progression.69,70. The gene discussed is CD274; the disease is neoplasm.